Eduardo Tejera

InstitutionUniversidad de Las Américas (UDLA)
AddressQuito
Ecuador
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 4 Covid-19 publications, with a maximum of 2 publications in February 2021
    All Publications
    Bar chart showing 38 publications over 14 distinct years, with a maximum of 7 publications in 2017 and 2019
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tejera E, Pérez-Castillo Y, Toscano G, Noboa AL, Ochoa-Herrera V, Giampieri F, Álvarez-Suarez JM. Computational modeling predicts potential effects of the herbal infusion "horchata" against COVID-19. Food Chem. 2022 Jan 01; 366:130589. PMID: 34311241.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    2. López-Cortés A, Guevara-Ramírez P, Kyriakidis NC, Barba-Ostria C, León Cáceres Á, Guerrero S, Ortiz-Prado E, Munteanu CR, Tejera E, Cevallos-Robalino D, Gómez-Jaramillo AM, Simbaña-Rivera K, Granizo-Martínez A, Pérez-M G, Moreno S, García-Cárdenas JM, Zambrano AK, Pérez-Castillo Y, Cabrera-Andrade A, Puig San Andrés L, Proaño-Castro C, Bautista J, Quevedo A, Varela N, Quiñones LA, Paz-Y-Miño C. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19. Front Pharmacol. 2021; 12:598925. PMID: 33716737.
      Citations: 5     
    3. Echeverría G, Guevara Á, Coloma J, Ruiz AM, Vasquez MM, Tejera E, de Waard JH. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay. Int J Infect Dis. 2021 Apr; 105:21-25. PMID: 33582369.
      Citations: 7     Fields:    Translation:HumansCells
    4. Tejera E, Munteanu CR, López-Cortés A, Cabrera-Andrade A, Pérez-Castillo Y. Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease. Molecules. 2020 Nov 06; 25(21). PMID: 33172092.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health